Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 52 (9), 1881-8

Autoantibodies to Zinc Transporter 8 and SLC30A8 Genotype Stratify Type 1 Diabetes Risk


Autoantibodies to Zinc Transporter 8 and SLC30A8 Genotype Stratify Type 1 Diabetes Risk

P Achenbach et al. Diabetologia.


Aims/hypothesis: Our aim was to determine the relationships between autoantibodies to zinc transporter 8 (ZnT8), genotypes of the ZnT8-encoding gene SLC30A8 and type 1 diabetes risk.

Methods: ZnT8 autoantibodies (ZnT8A) were measured in sera of 1,633 children with a first-degree family history of type 1 diabetes and who were prospectively followed from birth. Antibodies were measured by Protein A-based radiobinding assays and COOH-terminal (R325, W325 or Q325 variants) or NH(2)-terminal constructs of human ZnT8. SLC30A8 genotyping at single-nucleotide polymorphism (SNP) rs13266634 was performed on 1,170 children.

Results: Antibodies against COOH-terminal ZnT8 constructs (ZnT8A-COOH) developed in 58 children as early as 9 months of age (median 3 years). They were detected in 55 of 128 (43%) children with autoantibodies to insulin, GAD and/or insulinoma-associated protein 2 and 34 of 42 (81%) who progressed to diabetes. The additional presence of ZnT8A-COOH stratified diabetes risk in islet autoantibody-positive children (p < 0.0001). SLC30A8 genotype strongly influenced ZnT8A type and diabetes risk in ZnT8A-COOH-positive children. Antibody binding against the ZnT8 R325 variant was strictly correlated with the number of the corresponding SLC30A8 R325-encoding alleles, whereas binding against the W325 variant was highest in children who had SLC30A8 W325-encoding alleles (p = 0.001). Moreover, ZnT8A-COOH-positive children who carried homozygous SLC30A8 SNP rs13266634 genotypes progressed faster to diabetes than those who were heterozygous (59% [95% CI 42.3-75.7%] vs 22% [95% CI 0-44.3%] within 5 years; p = 0.01).

Conclusions/interpretation: Autoimmunity against the COOH-terminal region of ZnT8 is a highly relevant prognostic feature in childhood type 1 diabetes. Risk stratification in ZnT8A-COOH-positive children is further improved by SLC30A8 genotyping.

Similar articles

See all similar articles

Cited by 61 articles

See all "Cited by" articles


    1. Science. 2007 Jun 1;316(5829):1331-6 - PubMed
    1. J Clin Endocrinol Metab. 2003 Jan;88(1):103-8 - PubMed
    1. Ann Intern Med. 2004 Jun 1;140(11):882-6 - PubMed
    1. Science. 2007 Jun 1;316(5829):1336-41 - PubMed
    1. Diabetes Care. 1994 Feb;17(2):152-4 - PubMed

Publication types

MeSH terms

LinkOut - more resources